Bob Frantz of the San Francisco Examiner wrote an odious little column today in which he accused Jose Bautista of using performance enhancing drugs.
Well, he didn’t directly accuse him of doing so. No, he’s far too savvy for that. He merely wrote that “questions remain” regarding Bautista. Said that “normal men don’t go from 13 home runs as a part-time utility player one year to 52 home runs.” He merely suggested that Bautista submit to urine and blood tests and then have the results released to the public. He then blamed his suspicion and subtle character assassination on Jose Canseco, Rafael Palmiero, Roger Clemens and other people who presumably do not have editorial control over Frantz’s columns at the Examiner.
Of course, the fact that he blames Canseco et al, for his own cynical and evidence-free
suspicions of Bautista is intellectual dishonesty at its finest. He clearly suspects
Bautista of using PEDs. If he didn’t, he wouldn’t have been
inspired to write this piece. Well, he wouldn’t have unless the piece itself is a cynical exercise in filling column inches and stirring the pot by peddling crap that the author does not himself believe, but let’s save that for another time.
For now let us merely note that if Frantz has the guts to make an actual accusation, he should make it. To state, in plain language, that he doubts that Bautista’s accomplishments are genuine. To do otherwise — to make oblique reference to
the mere possibility that Bautista cheated and to blame
figures who haven’t played baseball for several years for “the questions
that remain” — is cowardly.
And that goes not only for Frantz, but for anyone who wishes to join in the increasingly popular pastime of trashing Jose Bautista. Ladies and gentlemen: if you have evidence, or even reasonable suspicion that Bautista — a
player who has had at least two PED tests this season — has used PEDs,
come out and say it. If you don’t, please spare us your insinuations to
Update (8:51 PM EST): The deal is in place, according to Heyman.
Update (8:27 PM EST): Derrick Goold of the St. Louis Post-Dispatch reports that the Cardinals made an “over-the-top offer” to Fowler to ensure he’d sign.
Frank Cusumano of KSDK Sports reports that free agent outfielder will take a physical in St. Louis on Friday. Presumably, that means that Fowler and the Cardinals have gotten pretty far along in negotiations.
Jon Heyman of FanRag Sports recently reported that Fowler was looking for $18 million per year. The Blue Jays reportedly made an offer to Fowler in the four-year, $16 million range several days ago. The Cardinals’ offer to Fowler, if there is indeed one, is likely somewhere between the two figures.
Fowler, 30, is coming off of a fantastic year in which he helped the Cubs win their first World Series since 1908. During the regular season, he hit .276/.393/.447 with 13 home runs, 48 RBI, 84 runs scored, and 13 stolen bases in 551 plate appearances.
Fowler rejected the Cubs’ $17.2 million qualifying offer last month. While the QO compensation negatively affected Fowler’s experience in free agency last offseason — he didn’t sign until late February with the Cubs — his strong season is expected to make QO compensation much less of an issue.
Tommy Stokke of RanRag Sports reports that the Braves and Rangers agreed to a trade. According to ESPN’s Keith Law, the Braves will receive pitcher Luke Jackson from the Rangers in exchange for pitchers Tyrell Jenkins and Brady Feigl.
Jackson, 25, is under team control through 2022. He has logged only 18 innings in the majors, yielding 14 runs on 22 hits and eight walks with three strikeouts. While Jackson has struggled with control, the Braves likely see upside because his fastball sits in the mid- to high-90’s.
Jenkins, 24, is also under team control through 2022. The right-hander made eight starts and six relief appearances in his first major league season in 2016, putting up a 5.88 ERA with a 26/33 K/BB ratio over 52 innings.
Feigl, 25, was an undrafted free agent and was signed by the Braves in 2013. The lefty underwent Tommy John surgery in 2015 and briefly rehabbed in rookie ball this past season.